DESERT VALLEY HOSPITAL INC.
1. Target Overview & Investment Thesis
DESERT VALLEY HOSPITAL INC. is a 138-bed suburban community hospital in SAN BERNARDINO, CA with $350.1M in net patient revenue and a 5.4% operating margin. The hospital serves a payer mix of 24.9% Medicare, 12.5% Medicaid, and 62.6% commercial.
Thesis: Turnaround. Our ML models identify $25.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.4% to 12.7% (+736bps).
| Net Revenue HCRIS | $350.1M |
| Current EBITDA COMPUTED | $18.7M |
| Operating Margin COMPUTED | 5.4% |
| Occupancy HCRIS | 79.6% |
| Revenue / Bed COMPUTED | $2.5M |
| Net-to-Gross HCRIS | 38.7% |
| Distress Probability ML | 42.4% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 5.4% places it above the state median. Among 198 size-comparable peers (69-276 beds), the median margin is -4.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (69-276), prioritizing same-state peers. 198 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DESERT VALLEY HOSPITAL INC. (Target) | CA | 138 | $350.1M | 5.4% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| CALIFORNIA PACIFIC MEDICAL CEN | CA | 274 | $987.8M | -18.5% |
| ENLOE MEDICAL CENTER | CA | 258 | $834.4M | -0.5% |
| KFH - SOUTH SACRAMENTO | CA | 233 | $803.9M | 5.9% |
| COMMUNITY HOSP. MONTEREY PENIN | CA | 227 | $797.2M | 9.3% |
| KFH - MANTECA | CA | 213 | $796.8M | 15.2% |
| LAC OLIVE VIEW/UCLA MEDICAL CE | CA | 225 | $754.9M | -10.5% |
| MARIAN MEDICAL CENTER | CA | 252 | $751.5M | 4.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $25.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $7.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $6.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $224K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $18.7M |
| + RCM Uplift | +$25.8M |
| Pro Forma EBITDA | $44.5M |
| Current Margin | 5.4% |
| Pro Forma Margin | 12.7% |
| WC Released (1x) | $13.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $28.8M | $381.3M | 13.23x | 67.6% |
| Base (11x exit) | 10.0x | 11.0x | $28.8M | $428.7M | 14.88x | 71.6% |
| Bull Case | 9.0x | 11.0x | $25.9M | $523.1M | 20.17x | 82.4% |
| Bull (12x exit) | 9.0x | 12.0x | $25.9M | $578.4M | 22.30x | 86.1% |
| Bear Case | 11.0x | 10.0x | $31.7M | $243.0M | 7.67x | 50.3% |
| Bear (11x exit) | 11.0x | 11.0x | $31.7M | $277.6M | 8.76x | 54.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 198 hospitals with 69-276 beds
- Same-state prioritization (n=199)
- Comp margins: P25=-18.3% / P50=-4.0% / P75=4.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.